1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Cannabis Strategic Ventures

Cannabis Strategic Ventures

NUGS
Cannabis Strategic VenturesUS flagOther OTC
0.00
USD
- -
- -
243,864.00Market Cap
2013 Y
2014 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
TTM
Revenue per Share
- -
0.02
- -
- -
- -
- -
0.01
0.02
Basic EPS, GAAP
- -
- -
- -
- -
-0.04
-0.08
-0.04
-0.04
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
-0.01
-0.04
-0.03
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
-0.73
-0.26
-0.22
-0.08
-0.14
-0.18
-0.17
Tangible Book Value per Share
- -
-0.01
-0.01
- -
- -
- -
-0.02
-0.03
Basic Weighted Avg Shares
- -
6
19
22
193
268
248
269
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
1
2
6
Operating Margin (%)
13.22
7.9
- -
- -
-35,116.68
-3,008.08
-294.16
-146.02
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
-8
-21
-9
-10
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
13.22
7.9
- -
- -
-52,943.53
-3,053.22
-382.51
-182.55
Working Capital
- -
- -
- -
- -
1
-1
-11
-12
LT Debt
- -
- -
- -
- -
- -
- -
8
7
Total Equity
- -
- -
- -
- -
1
- -
-6
-7
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-0.26
- -
-1.78
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Dec'20
Mar'20
Jun'21
ST Debt
11
14
15
LT Borrowings
- -
- -
- -
LT Finance Leases
8
8
7
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
269
267
269
Market Capitalization
8
13
21

Working Capital

FRC

•

in mil. unless spec.
Dec'20
Mar'20
Jun'21
Total Current Assets
3
4
5
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
1
1
1
Inventories
2
3
3
Total Current Liabilities
13
16
17
Payables & Accruals
1
1
1
ST Debt
11
14
15
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-504.75%
-1,466.62%
Free Cash Flow
- -
1,002.75%
330.49%
Net Income, GAAP
- -
-2,145.35%
-57.75%
Sales/Revenue/Turnover
- -
- -
237.25%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2019
- -
- -
- -
1
1
2020
- -
1
1
- -
2
2021
3
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2019
- -
-0.01
-0.01
- -
-0.08
2020
-0.01
-0.02
- -
- -
-0.04
2021
-0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2019
- -
- -
- -
- -
- -
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Simon Yu
Full Time Employees
30
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
833 South Spring Los Angeles CA United States of America 90014
IPO Date
Jul 24, 2009
CIK
0001290504
Website
cannabisstrategic.com
Similar Companies
Consun Pharmaceutical Group Limited (1681.HK)
MPH Health Care AG (0W1Q.L)
Kotra Industries Berhad (0002.KL)
Tristar Wellness Solutions Inc. (TWSI)
4Front Ventures Corp. (FFNT.CN)
Grape King Bio Ltd (1707.TW)
Business
Cannabis Strategic Ventures, Inc. (OTC: NUGS) engages in the cultivation and sale of cannabis biomass and related products to the legal cannabis market in the United States. The company incubates, develops, and partners within the cannabis and ancillary sectors, including through its subsidiaries such as NUGS Farm North, a state-licensed cannabis cultivator in California operating over six acres of greenhouse space; Pure Applied Sciences, Inc., which markets and sells the PureOrganics brand of cannabis oils and related accessories; Fitamins, Inc., focused on health and wellness products containing hemp-based cannabidiol (CBD); Lyxr, a brand offering skin, hair, and body topical solutions with hemp-based CBD and phytocannabinoids; and BudHire, a staffing solutions provider offering temporary, long-term, and permanent personnel for the cannabis industry in Washington and California. Founded in 2003 and headquartered in Los Angeles, California, the company primarily serves cultivators, manufacturers, dispensaries, and other participants in the cannabis marketplace across U.S. states with legal frameworks. In recent years, Cannabis Strategic Ventures has pursued strategic expansions, including the 2018 acquisition of Pure Applied Sciences to bolster its intellectual property and branding in cannabis extracts, and a partnership with Sunniva Inc. for white-label cannabis extraction services under the PureOrganics brand at a cGMP-compliant facility in California. The company also completed the acquisition of a controlling interest in Lyxr in 2019 for CBD-based beauty products and secured up to $3 million in investment funding in the same year to accelerate corporate growth. Although no major acquisitions, funding rounds, or operational shifts have been publicly announced in 2024 or 2025, the firm continues to focus on vertically integrating cultivation, processing, and ancillary services amid evolving U.S. cannabis regulations.